BCM
Bridgeway Capital Management Portfolio holdings
AUM
$4.21B
1-Year Return
17.73%
This Quarter Return
+9.42%
1 Year Return
+17.73%
3 Year Return
+87.27%
5 Year Return
+258.36%
10 Year Return
+515.25%
AUM
$4.21B
AUM Growth
+$243M
(+6.1%)
Cap. Flow
+$15M
Cap. Flow
% of AUM
0.36%
Top 10 Holdings %
Top 10 Hldgs %
8.22%
Holding
1,288
New
116
Increased
426
Reduced
381
Closed
108
Top Buys
| 1 |
Netflix
NFLX
|
+$23.5M |
| 2 |
IBM
IBM
|
+$20.5M |
| 3 |
AbbVie
ABBV
|
+$20.4M |
| 4 |
Advanced Micro Devices
AMD
|
+$20.4M |
| 5 |
Palantir
PLTR
|
+$20.3M |
Top Sells
| 1 |
TTM Technologies
TTMI
|
+$19.8M |
| 2 |
Pfizer
PFE
|
+$19.1M |
| 3 |
Qualcomm
QCOM
|
+$19.1M |
| 4 |
Comcast
CMCSA
|
+$19.1M |
| 5 |
Intel
INTC
|
+$19.1M |
Sector Composition
| 1 | Financials | 28.39% |
| 2 | Consumer Discretionary | 12.55% |
| 3 | Technology | 11.6% |
| 4 | Industrials | 11.34% |
| 5 | Energy | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
scPharmaceuticals
SCPH
$301M
| $259K | 0.01% |
67,900
| – | – |
|
902
Red River Bancshares
RRBI
$431M
| $259K | 0.01% |
4,407
| – | – |
|
903
Nature's Sunshine
NATR
$302M
| $257K | 0.01% |
17,379
-147
| -0.8% | -$2.17K |
|
904
Dakota Gold
DC
$513M
| $256K | 0.01% |
69,400
-50,000
| -42% | -$185K |
|
905
Allbirds
BIRD
$49.4M
| $253K | 0.01% |
23,831
| – | – |
|
|
KGEI
906
Kolibri Global Energy
KGEI
$191M
| $252K | 0.01% |
36,771
+1,765
| +5% | +$12.1K |
|
907
Y-mAbs Therapeutics
YMAB
$390M
| $251K | 0.01% |
55,700
+30,800
| +124% | +$139K |
|
908
Nerdy
NRDY
$157M
| $249K | 0.01% |
152,800
| – | – |
|
909
Alta Equipment Group
ALTG
$246M
| $249K | 0.01% |
39,400
| – | – |
|
910
SCYNEXIS
SCYX
$43.6M
| $248K | 0.01% |
368,180
+14,689
| +4% | +$9.91K |
|
911
W&T Offshore
WTI
$261M
| $248K | 0.01% |
150,000
| – | – |
|
|
CRGX
912
DELISTED
CARGO Therapeutics
CRGX
| $247K | 0.01% |
+60,000
| New | +$247K |
|
913
eHealth
EHTH
$115M
| $247K | 0.01% |
56,700
| – | – |
|
914
Codexis
CDXS
$219M
| $246K | 0.01% |
100,908
+6,300
| +7% | +$15.4K |
|
|
TECX
915
Tectonic Therapeutic, Inc. Common Stock
TECX
$324M
| $246K | 0.01% |
12,383
-2,285
| -16% | -$45.4K |
|
916
Trevi Therapeutics
TRVI
$1.17B
| $246K | 0.01% |
44,981
-35,000
| -44% | -$191K |
|
917
American Vanguard Corp
AVD
$152M
| $246K | 0.01% |
62,753
| – | – |
|
918
Neuronetics
STIM
$228M
| $245K | 0.01% |
70,205
+25,000
| +55% | +$87.3K |
|
919
8x8 Inc
EGHT
$285M
| $245K | 0.01% |
125,000
+75,000
| +150% | +$147K |
|
920
Black Diamond Therapeutics
BDTX
$183M
| $244K | 0.01% |
98,300
+25,200
| +34% | +$62.5K |
|
921
Spire Global
SPIR
$278M
| $238K | 0.01% |
20,000
| – | – |
|
922
InfuSystem Holdings
INFU
$206M
| $236K | 0.01% |
37,900
-30,000
| -44% | -$187K |
|
923
Inhibrx
INBX
$401M
| $235K | 0.01% |
+16,500
| New | +$235K |
|
924
Viemed Healthcare
VMD
$256M
| $235K | 0.01% |
34,000
+7,500
| +28% | +$51.8K |
|
925
Annexon
ANNX
$252M
| $235K | 0.01% |
+97,800
| New | +$235K |
|